Cleared Special

K042493 - ENSITE SYSTEM, MODEL EE3000

K042493 is an FDA 510(k) clearance for ENSITE SYSTEM, manufactured by Endocardial Solutions, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Special 510(k) pathway after a 31-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2004
Decision
31d
Days
Class 2
Risk

K042493 is an FDA 510(k) clearance for the ENSITE SYSTEM, MODEL EE3000. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Endocardial Solutions, Inc. (St. Paul, US). The FDA issued a Cleared decision on October 15, 2004 after a review of 31 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K042493

510(k) Number K042493 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 14, 2004
Decision Date October 15, 2004
Days to Decision 31 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
94d faster than avg
Panel avg: 125d · This submission: 31d
Pathway characteristics
Modification to existing cleared device.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 428
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K042493.
HEART RATE TURBULENCE ANALYSIS TECHNOLOGIES
K042148 · Ge Medical Syst. Information Technologies · Dec 2004
QRS-CARD CARDIOLOGY SUITE
K042799 · Pulse Biomedical, Inc. · Oct 2004
SYNESCOPE, EASYSCOPE, SYNECOM, HOLTERREADER
K042002 · Ela Medical, Inc. · Oct 2004
HOLTER PLUS
K042463 · Rozinn Electronics, Inc. · Sep 2004
ENDO PAT 2000
K032519 · Itamar Medical · Nov 2003
T-WAVE ALTERNANS (TWA) ALGORITHM OPTION
K032513 · Ge Medical Systems Information Technologies · Oct 2003